APAC Healthcare Weekly (Dec 15)-Daiichi Sankyo, Eisai, Celltrion, Metropolis Healthcare, CSPC Pharma
The insight covers key developments in prominent APAC healthcare companies. These developments are expected to impact the financials of the...
576 Views
Absolute Principles of Stock Investment (주식투자절대원칙) - A Book Review
This insight is a book review of 주식투자절대원칙 (Absolute Principles of Stock Investment), which was written by a famous Korean retail investor called...
1.4k Views
The First SRI Mutual Fund Aimed at Investing in Korean Companies that Promote Women
In the past week, Meritz Asset Management launched the "Meritz The Women Fund (메리츠더우먼펀드)," which is the first SRI Mutual Fund aimed at investing...
623 Views
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4.2k Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.6k Views